Luke A. Turnock

1 month ago | drugtopics.com | Brian Nowosielski |Luke A. Turnock |Jenny M. Markell

With an exponential rise in social media use combined with noticeable increases in drug advertisements, current drug market trends could lead to the normalization of specific prescription drugs for populations not approved to use them.

1 month ago | drugtopics.com | Brian Nowosielski |Luke A. Turnock |Jenny M. Markell

As society becomes more connected than ever thanks to emerging technologies, corporations are increasingly savvy with how they disseminate advertisements and marketing—whether it be through social media, television, streaming platforms, and more. One product of this increased connectivity is a noticeable rise in drug advertisements, making specific drugs for certain disease states common knowledge to everyday individuals.

1 month ago | drugtopics.com | Brian Nowosielski |Luke A. Turnock

Within the ever-connected social media age the world is currently living through, the need for individuals to enhance their physical performance and appearance has exponentially increased. Internet culture has long perpetuated these needs, forcing patients around the world to think differently about their looks and their health as more and more social media content is created.

2 months ago | drugtopics.com | Brian Nowosielski |Luke A. Turnock

While advertisements for prescription drugs have noticeably increased on television, overall promotion of prescription drugs has increased exponentially on social media channels. Amid influencers and brand ambassadors getting paid to promote products, on top of manufacturers promoting their own medications, researchers are skeptical about where these trends will lead the health of consumers that are commonly seeing these ads.

2 months ago | drugtopics.com | Brian Nowosielski |Luke A. Turnock

Luke Turnock, PhD, MSc, has done extensive research on prescription drug markets and how these products have been promoted on social media in recent history. He’s specifically versed in the promotion of weight-loss medications, testosterone replacement therapy (TRT), and sexual enhancement products. Throughout his research, he and his colleagues have uncovered an alarming normalization of these products that can potentially lead to poor outcomes for many consumers globally.